(PubMed) Jones W, Li X, Qu ZC, Perriott L, Whitesell RR, May JM
Snchez-Blzquez P, Rodrguez-Muoz M, Garzn J (2014) The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
Multi-targeted therapy of cancer by omega-3 fatty acids-an update
One particular injectable form of glutathione compounded by a manufacturer in Alabama has raised concerns with the FDA due to contamination by bacterial endotoxins, which produced life-threatening symptoms that began with: It is important to note that there is currently no FDA-approved injectable form of glutathione in the United States
Although our study demonstrates promising neuroprotective effects of irisin in an MPTP-induced Parkinsons disease model using male mice, it is essential to consider the potential impact of sex differences